SciSight Ecosystem
WoS SCIE Q3Scopus Q3SCImago #12,015CAS 4区Hybrid

Cancer Investigation

Abbreviation (ISO):CANCER INVEST
Country: United States•WoS SCIE Quartile: Q3•Scopus SJR: 0.495•SCImago Rank: #12,015•Identifier (ISSN):0735-7907(Print)/1532-4192(Online)•Articles / Year: 102•Estimated Publication Fee (APC): $2,986 USD
Clarivate IF (2026)Q3
2.2
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
102articles/year
6.7% Gold OA•77.94% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.2)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.2)
🔵 Computed
20251.50đ
WoS Q3(IF: 1.9)
🔵 Computed
20241.50đ
WoS Q3(IF: 1.8)
🔵 Computed
20231.50đ
WoS Q3(IF: 2.4)
🔵 Computed
20221.50đ
WoS Q3(IF: 2.368)
🔵 Computed
20211.50đ
WoS Q3(IF: 2.176)
🔵 Computed
20201.50đ
WoS Q3(IF: 2.398)
🔵 Computed
20191.50đ
WoS Q3(IF: 1.962)
🔵 Computed
20181.50đ
WoS Q3(IF: 2.053)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

Topics Covered (Recognized by AI)
Medicine98.6%Biology91.8%Internal medicine86.3%Genetics85.4%Cancer60.2%Chemistry53.8%Pathology51.1%Biochemistry45%Surgery40.9%Oncology40.3%Cancer research39.1%Immunology33.6%Chemotherapy25.8%Gene25%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,015Scopus Q3SCImago Profile
Scopus Coverage:1983-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.495

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
97

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.90

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,986 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations406
3-Year Documents243
Citable Documents216

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q3
OncologyQ3
Cancer ResearchQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Informa Healthcare
Publication Language
English
Frequency
Bimonthly
Founding Year
1983
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
228/333Q3
ONCOLOGY
JCISCIE
249/333Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—679
20251.992139
20241.873306
20232.467281
20222.36873588
20212.1761091,025
20202.398831,076
20191.96262782
20182.05352931
2017—661,179
2016—671,535
2015—711,487
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cancer Investigation

WoS Q3
1223201820192020202120222023202420251.90
Annual Impact Factor Metric
2025:1.9

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cec67236-fce9-4a26-a309-6bc42d27341b
Database Updated: 2026-10-01